{"name":"Intrepid Therapeutics, Inc.","slug":"intrepid-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Rare Disease","slug":"rare-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"CB-03-01","genericName":"CB-03-01","slug":"cb-03-01","indication":"Androgenetic alopecia (male pattern hair loss)","status":"phase_2"}]}],"pipeline":[{"name":"CB-03-01","genericName":"CB-03-01","slug":"cb-03-01","phase":"phase_2","mechanism":"CB-03-01 is a selective androgen receptor modulator (SARM) that inhibits 5-alpha reductase to reduce DHT-driven androgenetic alopecia.","indications":["Androgenetic alopecia (male pattern hair loss)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNOV9vN1FJQVBsZHJpOUREWW5JdXdKelZnM2lfd2J5X0xCWkhaTEVtc1dyZk9LVHVvMDhCbm53cGo4eERyU0VzMjJEMWo0TS03NlBXbjVMQW1uZ2FUU3VNal83Q3AtZEEzNnVoR3FUSjYzWGxaQlYyOTZ0bzR4dnVPYTdfNjlLcS1janpWN3R0dGU0YlZTNmxqLXhoTWFITm51eVA0YTNFaVBPeVNE?oc=5","date":"2025-10-27","type":"pipeline","source":"bizjournals.com","summary":"Orchestra Life Sciences relocates HQ to Philadelphia Navy Yard, plans rapid expansion - bizjournals.com","headline":"Orchestra Life Sciences relocates HQ to Philadelphia Navy Yard, plans rapid expansion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNcGoyd0UxODRYdURnSTdPZ283WmJHVWQtQm0xS1FOYzA4Vk96WjRrSEtQV2NPNmwtLXhSdEo3enZYOVFrTkR6TVhPeVhhVUppUW54clAxYTJsMWZ2VmRNRXo2SmpCNF9BX2t0eEtGN1VwN05Sc1g1TUhiT2hmTmtOZkxyNA?oc=5","date":"2025-01-12","type":"deal","source":"Yahoo Finance","summary":"Is Intrepid Potash (IPI) the Best Potash Stock to Buy According to Hedge Funds? - Yahoo Finance","headline":"Is Intrepid Potash (IPI) the Best Potash Stock to Buy According to Hedge Funds?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOdzRaUW5QQ2ZOOEVuWGJ5Z3VKX2FRV1BCY3BSdldoTmVpQ25TTHhUWDRtZDhvX1NxVDE1S3d1Yl9RSW5HM0ZRMWpLeGtMbGZlamNKVXVBcVlYS0R1dFdoYVJKdEk5N2lONElkRVcxajJrTnhwbVMwTlUtbndQLUg1Z1JXazZJTEMxOXVtT0pkaEpIUQ?oc=5","date":"2023-07-20","type":"pipeline","source":"Labiotech.eu","summary":"Seven pharma companies form alliance to prepare for future pandemics - Labiotech.eu","headline":"Seven pharma companies form alliance to prepare for future pandemics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNRmhsb1JuWl9ZbnhLN3pCeC1ieTczNWNlOHB3OFFqdTJrSDh1VzF5U2xaaTFWdmQ1QVFxSzFCcjhxNTFLbmhIZXNSMGhnVTNJbXFpbUtfZzd6aDlGTXdpN3E5U0EwVmRtSmpqMmE2eHkzdkRuS2JPTGxOQWx2U210Rk9tTXJKYmpVc19vd3dXMHpKRURUQ2Yzal9DdHFyeEJocDBrbE1Ia1I5SWNPNnZDc2VLS19zbHZPT0RfRzZDU2l5QVhVMXc?oc=5","date":"2020-09-11","type":"regulatory","source":"dicardiology.com","summary":"Medtronic Receives FDA Breakthrough Device Designation and Begins Trial for Intrepid Tricuspid Transcatheter Valve - dicardiology.com","headline":"Medtronic Receives FDA Breakthrough Device Designation and Begins Trial for Intrepid Tricuspid Transcatheter Valve","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQZDI1RkNJSS1OUEpHUDFPb29QZndkV05tak9XLTBCcUZYZVlHZndFQXR4emdwRUY2cVk0V1I3azlyM3daUUZtbHgyZ2FyOW9TVngzU2U4R0w5WkR1V1paaktSOGtjUFlWRk94UUZQM0Q3enQwNFpzVDA2clRNYl81ZzlPVnhTdjBXeUhnbEdvVVFvTXJtb0NJZw?oc=5","date":"2017-10-23","type":"trial","source":"dicardiology.com","summary":"First Patient Treated in Pivotal Trial for Medtronic TMVR Valve - dicardiology.com","headline":"First Patient Treated in Pivotal Trial for Medtronic TMVR Valve","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}